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ABSTRACT
Stereospecific Electrophilic Fluorination of Alkylcarbastannatrane Reagents
by
Xinghua Ma
Advisor: Prof. Mark R. Biscoe
The introduction of fluorine atoms into organic molecules significantly changes their
physical, chemical, and biological properties. Fluorinated organic compounds are used as
pharmaceuticals, agrochemicals, materials, and tracers for positron emission tomography (PET).
For example, the site-specific fluorination of drugs can block sites of phase I metabolism by
cytochrome P450 enzymes as well as improve target-binding affinities. In view of the unique
features of fluorine-containing compounds, there has been increasing interest in the development
of novel methods for the synthesis of fluorinated molecules, especially the site-specific
monofluorination of complex molecules. Herein, we present the enantiospecific conversion of
chiral secondary alkylcarbastannatranes into alkylfluorides. Carbastannatranes were used as
nucleophiles, with Selectfluor I as the electrophilic fluorinating agent, to afford alkylfluorides in
short reaction times. The addition of styrene as a radical trap was found to enhance
enantiospecificity. A broad range of alkylcarbastannatranes were converted into alkylfluorides
Vunder mild condition by this method. Other halogenations, such as chlorination, bromination and
iodination, were also applied to alkylcarbastannatranes with high enantiospecificity.
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11 Introduction
1.1. Importance of Molecules with Fluorine
Originally discovered by André-Marie Ampère in 1810, fluorine is the 13th richest element
in the Earth’s crust, and the 24th richest element in the universe. In 1886, French chemist Henri
Moissan succeeded in producing elemental fluorine by electrolyzing a mixture of potassium
fluoride and hydrogen fluoride. CaF2 is the major fluorine source for the fluorine industry.
Fluorine has interested the chemistry and pharmaceutical community since its discovery on
account of its special properties such as small size, high electronegativity, and low
polarisability.[1] The length of the C-F bond is almost the same as the length as the C-H bond
(1.39 and 1.09 Å, respectively) [1]. Therefore, introduction of one or more fluorine atoms into an
organic compound can result in changes of conformation and reactivity compared to those of the
non-fluorinated counterpart, without significant modification of steric properties. Perfluorinated
(fully fluorinated) organic compounds show particularly special properties. One example of a
fluorinated compounds that is used in everyday life is the polymer Teflon©, which is the coating
used in non-stick pans.
A major area of application for organofluorine chemistry is in pharmaceutical and
medicinal chemistry. The introduction of fluorine into bioactive molecules often results in
significant changes in their chemical, physical, and biological properties. Fluorine uniquely
affects the properties of organic molecules, increasing molecular lipophilicity and bioavailability.
No drugs containing a fluorine atom had been developed prior to the synthesis of 5-fluorouracil
21 in 1957. After that, the situation changed dramatically. Nowadays, there are many successful
examples of the introduction of fluorine into organic molecules, such as the anti-depressant
fluoxetine (prozac) 2, the anti-cholesterol atorvastatin (lipitor) 3, the anti-bacterial ciprofloxacin
(ciprobay) 4, HMG-CoA reductase inhibitor fluorostatin (atorvastatin) 5, the antibiotic
fluoroquinolone (levofloxacin) 6, and the antitumor fluoronucleoside (tegafur) 7. Approximately
30% of all agrochemicals and 20% of all pharmaceuticals contain fluorine.[2] Therefore,
fluorinating agents are useful tools to introduce fluorine for the synthesis of pharmaceutical and
agricultural compounds.
Scheme 1-1. Fluorinated Bioactive Compounds Pharmaceuticals
18F radiolabeled tracer molecules are commonly applied in Positron Emission Tomography
(PET), which is a nuclear medicine imaging technique used to diagnose many diseases,
including cancers, neurological disorders, heart disease, gastrointestinal and endocrine diseases,
and other abnormalities within the body. The general procedure for PET imaging is the
3following: a) isotopically labeled tracers are synthesized prior to performing imaging studies; b)
depending on the type of nuclear medicine exam, the radiotracer is either injected into the body,
swallowed as pills or inhaled as a gas, eventually accumulating in the organ or area of the body
being examined; and c) radioactive gamma emission from the radiotracer is detected by a special
camera or imaging device indicating the site of radiotracer accumulation. In PET imaging,
several radioactive isotopes with different half-lives can be employed. 11C (~20 min), 13N (~10
min), 15O (~2 min), 18F(~110 min), 68Ga(~67 min), 89Zr( 78.4 hours) and 82Rb(~1.27 min) are all
PET active nuclides.[3] The most commonly employed radiotracer for PET is
18F-fluorodeoxyglucose (18F-FDG) (Scheme 1-2), which is a radiolabeled analogue of glucose
that can be used to determine the sites of abnormal glucose metabolism. This is particularly
important for early detection of tumors.[4] Several electrophilic fluorinating agents for
radiofluorination have been reported (Scheme 1-3). Trifluoromethyl-18F-hypofluorite
(CF3-O18F),[5] acetyl-18F-hypofluorite (CH3-CO218F),[6] perchloryl-18F-fluoride (18F-FClO3),[7]
xenon difluoride (Xe18F2),[8] 1-18F-fluoro-2-pyridone, N-18F-fluoropyridinium triflate,
18F-fluoro-N-alkyl sulfonamide,[9] and 18F-Selectfluor bis(triflate)[10] have all been employed in
electrophilic [18F]fluorination.
Scheme 1-2. 18F-fluorodeoxyglucose
4Scheme 1-3. Electrophilic Fluorinating Agents for Radiofluorination
1.2. Current Methodology to Introduce Fluorine into Organic Molecules
Because of the importance of fluorinated organic molecules in medicinal chemistry, many
methods for installing fluorine into organic compounds have been developed. The following
section mainly reviews the most useful methods for introducing fluorine into organic molecules.
1.2.1. Traditional Methodology
Though nucleophilic fluorinating agents such as KF (Scheme 1-4),[11] CsF, and Bu4NF are
readily available, their reactivity is very low, and these reagents are highly hygroscopic.
Therefore, nucleophilic fluorinating reagents are not commonly employed in the absence of
catalysis. The most common fluorinating reactions can be classified into two categories:
deoxyfluorination reactions and electrophilic fluorination reactions.
Deoxyfluorination Reagents
Deoxyfluorination reagents are used synthetically to convert a hydroxyl group into a
fluorine atom (Scheme 1-5),[12] often stereospecifically (Scheme 1-6).[13] Diethylaminosulfur
5trifluoride (DAST) is the most commonly employed deoxyfluorination reagents. Several other
deoxyfluorination reagents are commercially available, such as bis(2-methoxyethyl) aminosulfur
trifluoride 8 (Deoxo-Fluor®) (Scheme 1-7),[14] 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride
9 (FluoleadTM) (Scheme 1-8),[15] Olah's reagent, and PhenoFluorTM 10. Deoxo-Fluor® exhibits
similar reactivity to DAST. However, it is more thermally stable, and shows increased reactivity
in some substrates, such as aldehydes, ketones and carboxylic acids. FluoleadTM shows high
thermal stability (decomposes at 232 oC) and can be handled in open air due to its low sensitivity
to water. Another important deoxyfluorination reagent is PhenoFluorTM, which is a crystalline
and nonexplosive solid. It was originally developed for deoxyfluorination of phenols to provide
a wide variety of aryl fluorides (Scheme 1-9).[16] In 2013, PhenoFluor was applied to
deoxyfluorination of aliphatic alcohols under appropriate modification of the reaction conditions,
that are compatible with a variety of functional groups (Scheme 1-10).[17] Later, the substrate
scope of deoxyfluorination was expanded to heteroaromatics (Scheme 1-11).[18] One drawback
of PhenoFluor is its high price ($0.80/mg) and its larger scale synthesis has been challenging. In
2015, a new deoxyfluorination reagent, 2-pyridinesulfonyl fluoride 11 (PyFluor) was reported
by Doyle,[19] which fluorinates a broad range of alcohols (Scheme 1-12).
Scheme 1-4. Nucleophilic Aromatic Substitution with KF
6Scheme 1-5. Cyclooctanol and Crotyl Alcohol Reacts with DAST
Scheme 1-6. DAST Reacts with Enantioenriched Alcohols
Scheme 1-7. Deoxo-Fluor Reacts with Alcohols
7Scheme 1-8. Fluorination of (2S,4R)-N-Fmoc-4-hydroxyprolinonitrile with FluoleadTM
Scheme 1-9. Deoxyfluorination of Phenols by PhenoFluor
Scheme 1-10. Deoxyfluorination of Aliphatic Alcohols by Phenofluor
8Scheme 1-11. Deoxyfluorination of Heteroaromatics by Phenofluor
Scheme 1-12. Deoxyfluorination with PyFluor
Electrophilic Fluorination
Most electrophilic fluorinating reagents are derived from fluorine gas. The traditional
regents, such as F2, XeF2, CsSO4F, and CF3OF, are highly oxidizing fluorinating reagents,[20]
which are not suitable for practical for general use due to the high reactivity of the reagents. The
stable and easy-to-handle crystal, N-fluoro-pyridinium salt, was reported by the Umemoto group
(Scheme 1-13, 14).[21] The reactivity could may be tuned by introducing groups with different
electronic properties into the pyridine ring. The counteranion also influences the reactivity,
selectivity, and stability of the reagent.[22] Another class of electrophilic fluorinating reagents is
sulfonyl derivatives RSO2N(F)R', which show different reactivities depending on the alkyl
9group R and R'.[23] N-Fluorobenzenesulfonimide (NFSI) is a member[24] of this class that became
popular in the early 1990s. It allows the fluorination of enolates, silyl enol ethers, aromatic
compounds, and organolithium compounds. Most recently, Selectfluor was developed as a
reliable, mild, and stable electrophilic fluorinating reagent. Selectfluor has been applied to a
wide scope of substrates, bearing functional groups, such as carbonyls, thioethers, and indoles.
Selectfluor derivatives[25] have also been reported, and their use in fluorination explored
(Scheme 1-15). 18F-Selectfluor was synthesized and evaluated by Gouverneur for applications to
radiofluorination.[10]
Scheme 1-13. The Summary of N-fluoro-pyridinium Salts
Scheme 1-14. Fluorination by N-fluoro-pyridinium salt
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Scheme 1-15. Selectfluor and Selectfluor derivatives
1.2.2. Fluorination of Organometallic Compounds
Organoboron Nucleophiles
Arylboron and alkylboron reagents are widely used in organic synthesis since they are
nontoxic, readily synthetically accessible, and stable to many common functional groups.[26]
Several metal-mediated methods to fluorinate organoboron compounds have been reported using
Pd (Scheme 1-16),[27] Ag (Scheme 1-17),[28] Cu (Scheme 1-18).[29] A fluorination reaction of
aryl boronic acids mediated by palladium forms carbon-fluorine bond at the final synthetic step,
which shows the functional group tolerance, broad substrate scope, and the regiospecificity of
the reaction. Fluorination of aryl trifluoroborates via copper was reported separately by Sanford
and Hartwig.[29a, b] The substrates can bear aryl aldehydes, ketones, amides and esters with good
yields. In 2014, an efficient and general method for fluorination of alklyboronates using AgNO3
in acidic aqueous solution was reported by the Li group (Scheme 1-19).[30] The method can be
used for alkylboronic acids, primary, secondary and tertiary alkylboronates. A radical
mechanism was proposed for this process.
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Scheme 1-16. Electrophilic fluorination with aryl palladium complexes
Scheme 1-17. Electrophilic Fluorination of Arylboronic Acids
Scheme 1-18. Cu(OTf)2 -Mediated Fluorination of Aryltriﬂuoroborates with KF
12
Scheme 1-19. Fluorination of Secondary and Tertiary Alkylboronates via AgNO3
In 2015, Aggarwal reported the fluorination of boronate complexes in the absence of metal
catalysis (Scheme 1-20).[31] The same strategy had also applied to different electrophilic
reagents to form C-C, C-N, C-Br, C-Cl, C-O and C-I bonds.[32] Enantioenriched secondary alkyl
boronate esters undergo enantiospecific substitution in this process. The nucleophiles were
derived from boronic esters and PhLi, which formed an activated ate complex in situ. This
intermediate was then treated with Selectfluor II to afford desired alkylfluorides. Styrene was
required as the radical trap to improve the enantiospecificity. The proposed pathway for the
reaction of boronate complex with Selectfluor II is shown in Scheme 1-21, including a possible
side reaction involving a radical mechanism.
13
Scheme 1-20. Fluorination of Boronate Complexes without any Metal Catalyst
Scheme 1-21. Proposed Pathways for the Reaction of Boronate Complex with Selectﬂuor
Organostannanes Nucleophiles
In recent years, many research groups put focus on the fluorination of organostannanes,
especially on arylstannanes. A silver-mediated process for the general fluorination of
functionalized arylstannanes has been reported by Ritter.[33] This reaction was shown to tolerate
aldehydes, unprotected hydroxyls, and heteroaryl groups. Later, they also reported
silver-catalyzed late-stage fluorination (Scheme 1-22),[34] which was the first fluorination report
exhibiting broad functional group tolerance and substrate scope, including carbohydrates,
peptides, polyketides, alkaloids and derivatives from taxol and rifamycin. Sanford has reported a
mild copper-mediated fluorination of aryl stannanes (Scheme 1-23),[29a] which does not require
14
any noble metal additives. The arylstannanes can bear electron-donating and
electron-withdrawing substituents.
Scheme 1-22. Silver-catalyzed Late-stage Fluorination
Scheme 1-23. Cu-Mediated Fluorination of Aryl Stannanes
15
Organosilicon Nucleophiles
Compared to fluorination of organoboron and organotin compounds, there are few papers
involving the fluorination of aryl silanes. Aryl silanes have their own advantages, such as low
toxicity, low price, and stability to a variety of reaction conditions. Reaction of
aryltrimethylsilanes with xenon difluoride in C6F6/Pyrex® at room temperature has provided aryl
fluorides in good yield,[35] however, aryltrimethylsilanes cannot carry electron-withdrawing
groups. In 2011, a regiospecific sliver-mediated fluorination of aryl silanes was reported
(Scheme 1-24) by Ritter.[36] However, to get optimal results, the silver salt (Ag2O) is used in
superstoichiometric amounts.
Scheme 1-24. ARegiospecific Silver-mediated Fluorination of Aryl Silanes
Grignard and Lithium Reagents as Nucleophiles
In 1900, Grignard reagents and reactions were reported by French chemist François
Auguste Victor Grignard, who was awarded the 1912 Nobel Prize in Chemistry for this work.
Following their discovery, Grignard reagents have been widely used in organic synthesis. Aryl
Grignard reagents have been used to form C-F bonds through reaction with electrophilic
16
fluorinating reagents without any metal catalyst.[37] The fluorination of primary alkyl Grignard
reagents was reported with decent yields (Scheme 1-25).[38] However, for secondary alkyl
Grignard reagents, few examples of fluorination exist, the yields are generally very low.[39]
Finally, lithium reagents could be applied into fluorinating process, especially for the aryl
lithium reagents (Scheme 1-26).[40] Up to now, the fluorination of organozinc reagents with
acceptable yield has not been reported. Therefore, no general conditions exist to broadly achieve
the fluorination of Grignard reagents, zinc reagents and lithium reagents.
Scheme 1-25. Fluorination of Grignard Reagents
Scheme 1-26. Fluorination of Aryl Lithium Reagents
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2. Stereospecific Fluorination of Alkylcarbastannatranes
2.1. Background
Organotin compounds have been used widely since the first organotin compound was
discovered in 1849. They have been applied in industry and in research labs as catalysts,
stabilizers, antifungal agents, agricultural fungicides, wood preservatives, and anti-biofouling
agents. Some organotin complexes have also been studied in anticancer therapy.[41]
A major application for organotin compounds is in Stille cross-coupling reactions (Scheme
2-1). Aryl trialkyl tin compounds are most commonly employed in Stille reactions because
nucleophilic transfer of aryl units occurs more rapidly than transfer of alkyl units. Some groups
have tried to transfer alkyl groups from tetraalkyl organotin compounds to metal catalysts,
however, the yields tend to be low and the reactions only work for primary alkyl groups.[42]
Therefore, tetraalkyltin compounds are rarely used in Stille reactions.
Scheme 2-1. The General Pd-catalyzed Stille Cross-coupling Reactions
In 2013, the stereoretentive Pd-catalysed Stille cross-coupling reactions of secondary alkyl
carbastannatranes under mild conditions was reported by our group (Scheme 2-2).[43] This was
18
the first general method to use secondary alkyltin reagents in cross-coupling reactions. The
heightened reactivity of alkyl carbastannatrane reagents results from the intramolecular
interaction between nitrogen and tin. Jurkschat and Tzschach showed that the nitrogen atom in
the atrane backbone selectively lengthens the Sn–C bond of the apical alkyl substituent by 0.1˚A
compared to the Sn–C bond of a tetraalkylstannane.[44] The transannular N-Sn bond enhances the
electron density of Sn atom and makes the cleavage of trans-disposed substituent easier. At the
same time, the atrane backbone structure stabilizes the Sn valence shell octet through N electron
donation. Therefore, the N-Sn transannular bond makes carbastanntranes efficient reagents for
the selective transfer of alkyl groups in Stille cross-coupling reactions. The Palladium-catalyzed
acylation of alkylcarbastannatranes was also reported by our group (Scheme 2-3).[45] Based
upon previous research and theory analysis, alkylcarbastannatranes remain promising candidates
for applications other than Pd-catalyzed cross-coupling reactions.
Scheme 2-2. Stereospecific Pd-catalyzed Cross-coupling Reactions of Unactivated,
19
Enantioenriched Secondary Alkylcarbastannatranes and Aryl Bromides
Scheme 2-3. Stereospecific Palladium-Catalyzed Acylation of Enantioenriched
Alkylcarbastannatranes
Metal-catalyzed fluorination was mainly achieved for aryl stannanes, as was discussed in
the previous section. While no example of the fluorination of alkylstannes has been reported,
there is precedent for the use of alkylstannanes in other halogenation reactions. In 1983, Jensen
had reported a mechanistic study of SE2 reactions on secondary alkyl organotin compounds 12,
which includes chlorination, bromination, and iodination (Scheme 2-4).[46] This work involved
investigation into the kinetics, stereochemistry, solvent effects, mixed halogen electrophiles
effects, and organotin structure effects. The stereochemistry of SE2 reactions was affected by the
nature of the electrophile and by the steric effects of the alkyltin nucleophile. However, the
report suggests the possibility of halogenation of organotin compounds with acceptable yield
and high enantioenriched compounds. Up to now, there has been no report of the fluorination of
alkyl organotin compounds with or without metal catalyst.
20
Scheme 2-4. Halogenation of Organotin 12 (% net inversion or retention shown).
2.2. Fluorination of Alkylcarbastanntranes
Though no example of the electrophilic fluorination of alkylstannanes has been reported,
the electrophilic fluorination reactions of boronate complexes, as demonstrated by the Aggarwal
group, suggests the possibility of fluorination of nucleophilic alkyl tin compounds. The primary
alkyl substrate, 5-decyl-1-aza-5-stannabicyclo[3.3.3]undecane 13, was chosen for initial
investigations of the fluorination reaction. Since Ritter has developed conditions for the
Ag-mediated and Ag-catalyzed fluorination of arylstannanes, Ritter’s conditions were initially
employed with alkyl carbastannatranes 13. Fortunately, the desired product was detected, and
the GC yield was 28%. However, it was also found the yield increased to 64% under the same
conditions in the absence of AgOTf (Scheme 2-5). Therefore, Ag catalysis is not necessary for
the fluorination of 13 using Selectfluor I 14. One possible reason for the low yield with AgOTf
is that alkylcarbastanntranes are so reactive that they decompose in the presence of AgOTf. To
investigate this proposal, 5-butyl-1-aza-5-stannabicyclo[3.3.3]undecane 15 was subjected to the
fluorination conditions without Selectfluor I but with the silver salt. It was found that
21
5-butyl-1-aza-5-stannabicyclo[3.3.3]undecane 15 decomposed very fast (less than 10 min. ),
even when the reaction was conducted at 0 ºC.
Scheme 2-5. Fluorination of Primary Alkylcarbastannatranes with and without Silver
A screen of temperature effects showed that fluorination was most efficient at room
temperature. At low temperatures, low yields were obtained though all of carbastannatrane was
consumed.
Entry Temperature GC yieldb (%)
1 120 ºC 36
2 90 ºC 48
3 Room temperature 64
4 0 ºC 55
22
5 -25 ºC 16c
a Reaction condition: carbastannatranes 13 (0.01 mmol), Selectfluor I (1.5 equiv), Na2CO3, (1 equiv), solvent 0.1
mL, Ar; bdodecane as the internal standard for GC yield calculation; Cfor 5-(4-phenylbutan-2-yl)-1-
aza-5-stannabicyclo[3.3.3]undecane.
Table 2-1. Fluorination of Alkylcarbastanntranes at Different Temperatures
Because transfer of a secondary alkyl group is more difficult than transfer of a primary
alkyl group, and because fluorination of secondary alkyl groups opens the possibility of
stereospecific fluorination, we chose to employ secondary alkylcarbastanntrane 17 for further
optimization reactions. The solvents were screened on 0.01 mmol scale reactions. Based on the
results of fluorination of 5-decyl-1-aza-5-stannabicyclo[3.3.3]undecane 13, we found that polar
solvents were necessary to dissolve Selectfluor I. The screen table is shown in Table 2-2. From
these results, it was apparent that use of CH3CN as the solvent provided the best yield of
fluorinated product.
Entry 1 2 3 4 5
Solvent CH3CN NMP DMF DMA DMSO
GCb yield (%) 70 26 55 49 0
a Reaction condition: carbastannatranes 17 (0.01 mmol), Selectfluor I (1.5 equiv), solvent 0.1 mL, rt, Ar; b
dodecane as the internal standard for GC yield calculation.
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Table 2-2. Fluorination of Alkylcarbastanntranes Using Different Solvents
Since the Sanford group has reported the electrophilic fluorination of aryl stannanes using
copper catalysis, the use of different copper catalysts was examined in this reaction (Table 2-3).
Unfortunately, it was found that the reaction yields decreased with the addition of copper salts. It
is possible that alkylcarbastanntranes decompose under these conditions. Indeed, transmetalation
of alkyl carbastannatranes to Cu (I) salts has been previously used by our group in
cross-coupling reactions.[43, 45]
Entry 1 2 3 4 5
Copper CuI CuTc Cu(OAc)2 Cu(acace)2
GCb yield (%) 70 17.6 12.9 30 7.5
aReaction condition: carbastannatranes 17 (0.01 mmol), Selectfluor I (1.5 equiv), copper salt (2 equiv), solvent
0.1 mL, rt, Ar; b dodecane as the internal standard for GC yield calculation.
Table 2-3. Fluorination of Alkylcarbastanntranes using Different Copper Additives
Because only highly polar solvents are capable of dissolving Selectfluor, lithium
tetrakis(pentafluorophenyl)borate was applied to the reactions as a phase transfer catalyst (PTC).
24
The addition of phase transfer catalysis did not improve yields significantly (Table 2-4). Other
additives such as Na2CO3, K3PO4, LiCl, Mg(OH)2, Cs2CO3, NaOH, NaCl, ZnCl2, and AlCl3were
also added into the fluorination reactions. It was found that they did not improve the yield, and
in some cases resulted in lower yields of fluorinated product.
Entry 1 2 3 4 5 6
Solvent CH3CN NMP DMF DMSO THF Toluene
GCbYield(%) 62 32 45 0 0 0
aReaction condition: carbastannatranes 17 (0.01 mmol), Selectfluor I (1.5 equiv), B(C6F5)4Li (0.5 equiv), solvent
0.1 mL, Ar, rt; b dodecane as the internal standard for GC yield calculation.
Table 2-4. Fluorination of Alkylcarbastanntranes with Phase Transfer Catalyst
Even though the fluorination of
5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane 17 provided a decent yield, it was
still necessary to perform a control of tetraalkyltin compounds using the conditions developed
for alkyl carbastannatranes. The commercially available compound, tetracyclohexyl tin 19, was
used for these reactions. Using a variety of polar and non-polar solvents with and without a PTC
additive, no fluorination product was observed from 19. Entry 6 employed Ritter’s conditions
25
for aryl stannanes, however, still did not result in formation of the desired product.
Entry Solvent (mL) Additive/Catalyst Yieldb (%)
1 CH3CN (0.2) 0
2 c-Hex (0.15)/CH3CN (0.15) LiB(C6F5)4 (0.2 equiv) 0
3 cyclohexane (0.3) 0
4 ether (0.3) 0
5 ether (0.15)/CH3CN (0.15) 0
6 acetone (0.3) AgOTf (2 equiv) 0
aReaction condition: tetracyclohexyl tin 19 (0.01 mmol), Selectfluor I (1.5 equiv), solvent 0.1 mL, Ar, rt; b
fluorobenzene as the internal standard 19F NMR yield calculation.
Table 2-5. Fluorination of Tetracyclohexyl Tin
Next, we investigated the use of different electrophilic fluorinating reagents in reactions
with alkylcarbastanntranes. With the development of electrophilic fluorination, several
fluorination reagents with different reactivity, oxidation ability, and solubility, have become
commercially available. Fluorodi(benzenesulfonyl)amine (NFSI) 21, 1-fluoropyridinium triflate
22, 1,1′-difluoro-2,2′-bipyridinium bis(tetrafluoroborate) 23 and N-fluoropyridinium pyridine
heptafluorodiborate 24 were developed as possible alternatives to Selectfluor. The best yield
26
with fluorodi(benzenesulfonyl)amine (NFSI) 21 was 48% in toluene (Table 2-6). However, no
desired product formed using other fluorinating reagents such as 1-fluoropyridinium triflate 22,
1,1′-difluoro-2,2′-bipyridinium bis(tetrafluoroborate) 23 and N-fluoropyridinium pyridine
heptafluorodiborate 24. There was a difference between use of 1-fluoropyridinium triflate 22
and the use of 1,1′-difluoro-2,2′-bipyridinium bis(tetrafluoroborate) 23 and N-fluoropyridinium
pyridine heptafluorodiborate, 24. While the alkylcarbastannatrane starting material remained in
1-fluoropyridinium triflate reactions, there was no alkyl carbastanntranes left in
1,1′-difluoro-2,2′-bipyridinium bis(tetrafluoroborate) 23 and N-fluoropyridinium pyridine
heptafluorodiborate 24 after reactions using certain solvents. Basing on those results, it was
possible that BF4- or B2F7- may affect the fluorination or alkylcarbastanntrane. Therefore,
compound 25 was prepared (Scheme 2-6), which were verified by 19F NMR. When compound
25 was applied in fluorination reactions, the yield was not improved.
Entry Solvent (0.1mL) GC Yield (%)
NFSI 22 23
1 CH3CN 31 0d 0
2 DMF 24 0d 0
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3 THF 39 0d 0
4 toluene 48 0c 0c
5 CH3OH 21 0c 0
6 ClCH2CH2Cl 19 0c 0c
aReaction condition: carbastannatranes 17 (0.01 mmol), fluorinating reagent (1.5 equiv), solvent 0.1 mL, Ar, rt;
bdodecane as the internal standard for GC yield calculation; ca lot of carbastanntrane left; dsome
carbastanntrane left.
Table 2-6. Fluorination of Alkylcarbastanntranes with different Fluorinating Reagents
Scheme 2-6. Synthesis of Selectfluor Derivative 25
One of the most important applications for mono-fluorinated organic compound is in PET
imaging using. The half-life time of 18F isotope is around 108 min. Therefore, if the reaction
could be performed in minutes with decent yield, it would be more practical and
alkylcarbastannatranes would be potential candidates for PET technique. When conversion of
substrate 17 was monitored as a function of time, it was found that the fluorination can be done
in 5 min with 60% GC yield. It was also found fluorination rate of secondary
alkylcarbastanntranes would be faster than its of primary carbastanntranes. The fluorination of
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primary alkylcarbastanntranes requires one hour at room temperature.
Up to now, one problem for most fluorination reactions was that it would have
rearrangement product or reduction/elimination product. Those byproducts would have similar
physical and chemical characteristics as desired product, such as close boiling point, and polarity.
Hence, the purification of desired product would be difficult. Fortunately, fluorination of
alkylcarbastanntranes did not form reduction/elimination or rearrangement byproducts.
Entry Variations from above Yieldb (%)
1 none 62
2 0 ºC instead of rt; 2 h instead of 5 min 50
3 Selectfluor II instead of Selectfluor I 50
4 NFSI 21 instead of Selectfluor I 31
5 22 Instead of Selectfluor I 0
6 DMSO instead of CH3CN, 2 h instead of 5 min 0
7 DMF instead of CH3CN; 2 h instead of 5 min 45
8 methanol instead of CH3CN; 2 h instead of 5 min 39
9 Cy4Sn instead of 17; 2 h instead of 5 min 0
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a Reaction condition: carbastannatranes 17 (0.01 mmol), fluorination reagent (1.5 equiv), solvent 0.1 mL, Ar, rt; b
dodecane as the internal standard for GC yield calculation.
Table 2-7. Fluorination of Alkylcarbastanntranes
Based upon the series of screens, the optimized condition was found and representative
factors was summarized in Table 2-7. Using the optimized condition, the substrate scope of this
fluorination reaction was explored (Scheme 2-7). Most of racemic alkylcarbastanntranes were
prepared from carbastanntranes chloride with corresponding Grignard reagents or zinc reagents.
The primary alcohol carbastanntrances could be prepared by reduction of ester carbastanntranes
or removal of OTBS group. The reactions were run on 0.25 mmol scale twice. The yield was
calculated by 19F NMR, in which fluorobenzene was used as the internal standard. Meanwhile, it
was also confirmed by GC calculation yield. Most of fluorination products were confirmed by
GCMS or HRMS, for those products were volatile. The yield range was from 50% to 70%. The
fluorinations were run under mild conditions, so that sensitive functional groups were well
tolerated, such as alcohols, ester, boronate esters and silyl ether. For alcohol substrate 37, it was
hard to find one method to prepare it directly. Boronate ester would be potentially useful for
further organic synthesis, for reactive Bpin group has a wide application, such as conversion to
alcohol and Suzuki reaction nucleophile. Fluorination of an oxygen- containing heterocycle also
proceeded smoothly. Because the C–Sn bond alkyl carbastanntranes tolerates even the harshest
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reduction conditions, remote functional groups can be readily modified without disturbing the
carbastannatrane fragment. Thus, our fluorination process should enable late-stage access to
potentially important fluorinated molecules that would be particularly difficult, if not impossible,
to prepare using existing methods of direct fluorine incorporation.
Scheme 2-7. Electrophilic Fluorination of Alkylcarbastannatranes
Once primary and secondary alkycarbastanntranes were successfully fluorinated with
decent yield. The tertiary alkylcarbastanntranes were tried to to be synthesized and employed
into fluorination. There were three possible compounds for intended testing. However, it was
found that the synthesis of compound 43 and 44 failed at last step, reaction between
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corresponding zinc (or lithium) reagent with carbastanntranes chloride. The reason was
unknown. Up to now, we only can successfully synthesize
5-(tert-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane 45. For the potential product would have
very low boiling point, so the fluorination was run at 0 oC. On 19F NMR, it showed the possible
peak from 2-fluoro-2-methylpropane 46.
Scheme 2-8. Potential Tertiary Alkyl Carbastanntranes and Fluorination of
5-(tert-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane
Except fluorination, other electrophilic halogenations were employed onto alkyl
carbastanntranes. In the chlorination reactions, two chlorinating reagents, trichloroisocyanuric
acid (TCCA) 47 and N-chlorosuccinimide (NCS) 48, were used for screen (Table 2-8). It was
found that TCCA would be a better one and could be used into different solvents with decent
yield, such as acetontirle, DMF, THF, and toluene. Narrowing down the range of solvent range,
bromination and iodination were tested. In all, to keep the same condition as fluorination,
acetonitrile was chosen for larger scale reactions. Using primary and secondary alkyl
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carbastannatrane nucleophiles, the corresponding chlorinated, brominated (Table 2-9), and
iodinated products (Table 2-10) were cleanly produced in good yield through reactions with
trichloroisocyanuric acid 47, N-bromosuccinimide (NBS) 49, and iodine, respectively.
Entry Solvent Cl+ GC yieldb (%)
1 CH3CN TCCA 68
2 DMF TCCA 68
3 DMSO TCCA 7
4 THF TCCA 67
5 toluene TCCA 67
6 CH3CN NCS 55
7 DMF NCS 11
8 THF NCS 9
9 MTHF NCS 13
aReaction condition: carbastanntrane 17 (0.01 mmol), chlorinating reagents (1.5 equiv.), solvent (0.1 mL), rt, under
Ar; b dodecane as the internal standard for GC yield calculation.
Table 2-8 Optimization of Chlorination of 5-(4-phenylbutan-2-yl)-1-aza-5- stannabicyclo [3.3.3]
undecane
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Entry 1 2 3
Solvent CH3CN THF MTHF
GC yieldb (%) 70 71 63
aReaction condition: carbastanntrane 17 (0.01 mmol), NBS (1.5 equiv.), solvent (0.1 mL), rt, under Ar; bdodecane as
the internal standard for GC yield calculation.
Table 2-9 Optimization of Bromination of 5-(4-Phenylbutan-2-yl)-1-aza -5-stannabicyclo
[3.3.3]undecane
Entry 1 2 3 4
Solvent CH3CN DMF THF toluene
GC yieldb (%) 64 53 54 53
aReaction condition: carbastanntrane 17 (0.01 mmol), I2 (1.5 equiv.), solvent (0.1 mL), rt, under Ar; bdodecane as
the internal standard for GC yield calculation.
Table 2-10 Optimization of Iodination of 5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo
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[3.3.3]undecane
Using primary and secondary alkylcarbastannatrane nucleophiles, the corresponding
chlorinated, brominated, and iodinated products were cleanly produced in good yield (Scheme
2-9) through reactions with trichloroisocyanuric acid (TCCA), N-bromosuccinimide (NBS), and
iodine, respectively. Thus, alkylcarbastannatranes can be broadly utilized in electrophilic
halogenation reactions with one set of reaction conditions
Scheme 2-9. Electrophilic Halogenation of alkylcarbastanntranes
Other alkylcarbastannatranes with heteroatom (Scheme 2-10), such as
5-(3-(thiophen-2-yl)propyl)-1-aza-5-stannabicyclo[3.3.3]undecane 60,
9-(3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)propyl)-9H-carbazole 61, and
5-(1-methylpiperidin-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane 62 were designed to
synthesize for followd fluorination. Unfortunately, it is difficult to synthesize these
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carbastanntranes and the fluorination of carbastanntranes 60 and 62 results in only trace of
desired product.
Scheme 2-10. Alkylcarbastannatranes with Heteroatom
To understand the mechanism of fluorination of alkylcarbastanntranes, the enantioenriched
alkylcarbastanntranes were synthesized by two routines (Scheme 2-11). One routine was to
prepare enantioenriched alkylcarbastanntranes from enantiroenriched mesylate by SN2 reaction
with (1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)lithium 63. Another routine was that racemic
alkylcarbastanntranes prepared from Girgnard or zinc reagents were separated by chiral HPLC.
Scheme 2-11. Synthesis of Enantioenriched Alkyl Carbastanntranes. a) mesyl chloride, TEA,
CH2Cl2; b) (1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)lithium, THF; c) carbastanntrane chloride;
d) chiral HPLC.
Enantioenriched compound 64 was initially employed to react with Selectfluor I at room
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temperature. The e.s. value was 81% on 0.01 mmol scale reaction. To improve enantiospecificity
of fluorination, some conditions were screened on 0.01 mmol scale reactions. Selectfluor II
provided the similar es value as Selectfluor I at -5 oC in the reaction. However, the fluorination
yield from Selectfluor II was very low at -5 oC. Once some other polar solvents, such as DMF
and MeOH, were used for the fluorination and provided high enantiospecific desired product.
The yield went down for those solvents when reactions were run at -5 oC. Some alcohols, such
as ethanol, isopropanol, and tert-butanol, were employ into fluorinations at room temperature.
Unfortunately, there was no desired product. The entry 3 would be the optimized condition for
fluorination of enantioenriched alkyl carbastanntranes. Enantioenriched ethyl
3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate also were used for screening as the
substrate. It provided the similar results as of compound 64.
Entry Solvent (0.1 mL) Temperature Selectfluor es (%)
1 CH3CN rt I 81
2 CH3CN rt II 65
3 CH3CN -5 oC I 90
4 CH3CN -5 oC II 91
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5 DMF rt I 88
6 DMF -5 oC I NAb
7 CH3OH rt I 88
8 CH3OH -5 oC I NAb
aReaction conditions: carbastanntrane 64 (0.01 mmol), electrophile (1.5 equiv), solvent 0.1 mL, Ar.; bThe yield was
too low.
Table 2-11. Fluorination of Enantioenriched Alkylcarstanntrane with Different Solvents and
Temperature.
The optimized condition from 0.01 mmol scale reactions could not be applied into the
larger scale fluorination, even it was just 0.025 mmmol. The enantiospecifity of fluorination was
62% at -5 oC for 0.025 mmol scale reaction. As we all know, Selectfluor I reaction would
undergo radical mechanism, which resulted in partially racemization. One general method was
addition of radical trap, which was also reported in Aggrawal’s fluorination paper. It was found
that styrene would be the best radical trap at -5 oC. (Table 2-12)
Entry Radical trapper Temperature es (%)
1 TEMPO rt NAb,d
2 BHT rt 51b
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5 Styrene -5 oC 83c
6 Styrene rt 58c
7 Sulfide rt NAb,d
8 9,10-dihydroanthracene rt 81
aReaction conditon: carbastanntrane 64 (1 equiv.), electrophile (1.5 equiv), solvent (0.1 mL for 0.01 mmol reaction;
0.2 mL for 0.025 mmol reaction); b 0.01 mmol scale reaction; c 0.025 mmol scale reaction; d no desired product.
Table 2-12. Fluorination of Enantioenriched Alkylcarstanntrane with Different Radical Trap
During the fluorination procedure, it may form cation [N(CH2CH2CH2)3Sn]+ 66, which was
reported by Fillion.[47] The cation may react with enantioenriched alkylcarbastanntranes to form
corresponding enantiomer, which would result in racemization. To reduce the possible formation
of enantiomer, some additives were added into fluorination, such as PPh3, pyridine,
triethylamine, pyrrolidine, tetrabutylammonium fluoride, and 4-(dimethylamino)pyridine. It was
found that pyridine would improve the fluorination enantiospecificity.
Up to now, a series of factors have been investigated, such as solvents, reaction temperature,
radical trapper, and additives. It was found that the optimized condition for fluorination required
styrene and pyridine at -5 oC and this condition could be used for 0.1 mmol scale reactions.
Using the optimized conditions, the scope of substrates was explored. When an enantioenriched
benzylcarbastannatrane was employed in this fluorination reaction, low stereospcificity was
observed (Scheme 2-12). The increased propensity of benzylic nucleophiles to react via radical
pathways when in the presence of strongly oxidizing reagents such as Selectfluor I.
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Scheme 2-12. Fluorination of (S)-5-(1-phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane
Without styrene and pyridine, highly stereospecific halogenations (chlorination,
bromination and iodination) were achieved under standard conditions. For iodination, iodine
was not a suitable electrophile for stereospecific reaction. To improve the enantiospecifity, two
more different electrophiles, N-chlorosuccinimides (NIS) 69 and ICl, were used for screen.
Based upon the results, NIS was chosen as the electrophile and THF as the solvent for iodination
(Table 2-13). Those conditions could be used for 0.1 mmol scale reactions
Entry Electrophile Solvent esb (%) GC yieldc(%)
1 I2 CH3CN 70d 64
2 NIS CH3CN 97e 11
3 ICl CH3CN 83e 49
4 NIS THF 93d 55
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aReaction condition: carbastanntrane 64 (1 equiv), electrophile (1.5 equiv), solvent (0.1 mL for 0.01 mmol reaction;
0.2 mL for 0.025 mmol reaction); b at -5 oC; c at rt, dodecane as the internal standard; d 0.025 mmol; e0.01 mmol.
Table 2-13. Optimization of Iodination of 5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo
[3.3.3]undecane
The enantioenriched secondary alkyl carbastanntranes were employed into halogeantion
with the best condition, as discussed above. The enantiospecificity of fluorination range is from
83% to 90%, however, other stereospecific halogenation of enantioenriched
alkylcarbastannatranes can be achieved with only nominal loss of enantiopurity. This enables the
direct preparation of optically active alkyl halides from enantioenriched alkylcarbastannatranes.
Scheme 2-13. Stereosepecific electrophilic halogenations of enantioenriched
alkylcarbastannatranes
2.3. Investigation of Mechanism
The high stereospecific halogenations of enantioenriched alkylcarbastanntranes were
achieved. It was necessary to probe the proposed mechanism. Aggarwal and Jensen have
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previously demonstrated the use of polar solvents such as acetontirile and methanol support a
stereoinvertive SE2 mechanism in which charge separation is expected to occur in the transition
state. Meanwhile, the intrannular Sn←N would stablize cation [N(CH2CH2CH2)3Sn]+, that
would be helpful for the SE2 inversion mechanism. The
(S)-5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane 81 was prepared from
(R)-4-phenylbutan-2-ol 82 and (S)-(3-fluorobutyl)benzene 83 was prepared from
(R)-4-phenylbutan-2-ol 82 with DAST. By comparing the two fluoride enantiomers on chiral
HPLC results, it was confirmed that fluorination of alkylcarbastanntranes was stereoinvertive
SE2 mechanism.
Scheme 2-14. Investigation of mechanism. a) mesyl chloride, TEA, CH2Cl2; b)
(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)lithium, THF; c) Selectfluor I, styrene, pyridine,
CH3CN; d) DAST, CH2Cl2.
For the fluorination of alkylcarbastanntranes, there are three possible mechanism (Scheme
2-15), radical mechanism, SE2 retention mechanism, and SE2 inversion mechanism.
Comprehensive current results analysis and literature, SE2 inversion mechanism would be
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primary.
Scheme 2-15. The Possible Mechanisms for Fluorination of Alkylcarbastanntranes
2.4. Fluorination of Arylcarbastanntranes.
Since many research groups reported fluorination of arylstannanes recently,
arylcarbastanntranes would be the choice for the fluorination. It may be able to provide the very
fast reaction, which will be suitable for the PET technique. The arylcarbastanntranes were
prepared by Grignard reagents (or lithium reagents) with carbastanntrane chloride 86 at -78 oC
(Scheme 2-16). The Ritter’s conditions fo the silver-mediated fluorination of arylstannes were
applied to the fluorination of aryl carbastanntranes (Scheme 2-17), fortunately, there was a
product peak on 19F NMR. However, one major problem came out, there was a limitation of the
aryl carbastanntranes. It was found that only 5-phenyl-1-aza-5-stannabicyclo[3.3.3]undecane (88)
was able to be isolated. Once there were some electron-donating groups on phenyl 89, desired
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compounds were not isolable, for it may react with moisture or oxygen very quickly. Meanwhile,
it was hard to prepare the phenyl lithium or Grignard reagents if they were attached with
electron-withdrawing groups. The same procedure without silver catalyst was also applied onto
arylcarbastanntranes with Selectfluor I. No possible product was found on 19F NMR. Hence,
there was no advantage over traditional tri-n-butyl aryl stannanes.
Scheme 2-16. Synthesis of Racemic Arylcarbastannatranes
Scheme 2-17. Fluorination of Arylcarbastanntranes via AgOTf
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3. Conclusion
In summary, the fluorination of primary and secondary alkylcarbastanntranes was studied.
The reactions occur without the need of any catalysts or in situ activation of the nucleophile at
room temperature due to carbastannatrane backbone activation. Meanwhile, chlorination,
bromination, and iodination were also employed onto primary and secondary
alkylcarastanntranes under the same conditions.
For enantioenriched alkylcarbastanntranes, the fluorination reactions would proceed
through a SE2 invertive mechanism with styrene as the radical trap at 0 oC. That provides the
routine to prepare optically active alkyl fluorides from enantioenriched alkylcarbastannatranes.
This type of stereospecific electrophilic halogenation also included chlorination, bromination
and iodinantion.
This reaction constitutes an exceedingly rare example of the direct, stereospecific
functionalization of configurationally stable, isolable, main group organometallic nucleophiles.
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5.1. General Reagent/Analytical Information
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF
(unstabilized) was also purchased from VWR. These solvents were transferred to separate 20 L
solvent-delivery kegs and vigorously purged with argon for 2 h. The solvents were further
purified by passing them under argon pressure through two packed columns of neutral alumina.
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane and Selectfluor I were purchased from
Sigma-Aldrich. Acetonitrile (Sigma-Aldrich) was purged with argon prior to use. Grignard
reagents were prepared from their corresponding alkyl chlorides or bromides using a literature
procedure[1]. Molarities of Grignard reagents and zinc reagents were determined using iodine
titration[2]. Optically active alkylcarbastannatranes were prepared via preparatory chiral HPLC
of the racemate or using a previously reported literature procedure.[3] Reagents and solvents
were used as received unless otherwise noted. Flash chromatography was performed using
Silicycle silica gel (ultra-pure grade).
All NMR spectra were obtained on a Varian 500 (500 MHz for 1H and 125 MHz for 13C), a
Varian 300 (282 MHz for 19F) or a Bruker 300 (300 MHz for 1H, 75 MHz for 13C and 282 MHz
for 19F). All previously unreported compounds were additionally characterized by high
resolution MS. All 1H NMR experiments are reported in δ units, parts per million (ppm), and
were measured relative to the signals for residual chloroform (7.26 ppm) unless otherwise noted.
The following abbreviations are used to express the multiplicities: s = singlet; d = doublet; t =
triplet; m = multiplet; br = broad, app = apparent. All 13C NMR spectra are reported in ppm
relative to deuterochloroform (77.23 ppm), and were obtained with 1H decoupling. High
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resolution MS analyses were performed on an Agilent 6520 Q-TOF instrument. All GC analyses
were performed on a Shimadzu GC-2010 gas chromatograph with an FID detector using a 25 m
x 0.20 mm capillary column with cross-linked methyl siloxane as the stationary phase, or using
a 30 m x 0.32 mm chiral column (Rt®-βDEXsm from RESTEK). All low boiling point fluoride
compounds were confirmed by GCMS on Shimadzu GC-MS QP2010S or high resolution MS.
All GC yields were calibrated using dodecane or tetradecane as an internal standard. Chiral
HPLC analyses were performed using a Shimadzu Prominence HPLC system with binary
mobile phase pumps and UV-vis detector (LC-20AB, SPD-20A) using an OJ-RH (dimensions:
4.6 mm x 150 mm; particle size: 5 μm) chiral column (DAICEL CHEMICAL IND., LTD.), or an
IA (dimensions: 4.6 mm x 150 mm; particle size: 5 μm) chiral column (DAICEL CHEMICAL
IND., LTD.)
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5.2. General Procedural Information
Preparation of alkylcarbastannatranes:
General procedure A (preparation of achiral and racemic alkylcarbastannatranes):
Grignard reagents were prepared from the corresponding alkyl chlorides. All reactions were
performed in oven-dried glassware under an atmosphere of Ar. The alkylmagnesium reagent
(or alkylzinc reagent for ethyl butanoate nucleophile) (2.0-3.0 equiv) was added to a suspension
of 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane1 (1 equiv) in THF at -78 °C. The resulting
mixture was stirred at -78 °C for 3 h, allowed to warm to room temperature, and stirred
overnight. The reaction mixture was poured into a separatory funnel containing a mixture of
water and ether. The organic layer was separated, washed with brine, dried over Na2SO4, and
filtered. Solvent was removed under reduced pressure, and the remaining compound was dried
in vacuo to provide the crude product. The crude alkyltin reagents were used without
purification, or following purification via Kugelrohr distillation or C18 chromatography.
Homocoupling from Grignard formation constituted the major residual byproduct in the crude
product.
General procedure B (preparation of enantioenriched alkylcarbastannatranes):
To an oven-dried round bottom flask containing a stirbar,
5-chloro-1-aza-5-stanna-bicyclo[3.3.3]undecane (588 mg, 2 mmol) and naphthalene (128 mg, 1
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mmol) were added. The flask was evacuated (<100 mtorr) and backfilled with argon three
times. With the flask under a flow of argon, the septum was removed and lithium granules (free
of oil) (250 mg, 35 mmol) were added. This was followed by two additional evacuation/backfill
cycles. Anhydrous THF (40 mL) was added to the flask via syringe, and the mixture was stirred
at room temperature. The solution turned dark green/black within 30 min. Upon color change,
the solution was stirred at room temperature for an additional hour. In a separate 100 mL flask
under argon, with stirbar and rubber septum, the optically active alkyl mesylate (1.2–1.5 equiv)
was dissolved in anhydrous THF (20 mL). The mesylate solution was heated to 60 °C. The
stannatrane lithium mixture was removed from the excess lithium via cannula or needle/syringe,
and transferred dropwise to the mesylate solution over 5 mins. The reaction stirred at 60 °C for
an additional hour. The reaction mixture was extracted with ethyl ether (60 mL), followed by
brine (100 mL), and dried over Na2SO4. The reaction solution was filtered and concentrated to
provide the crude product. The crude product was purified (40–50% isolated yield) by C18 silica
(80/20 acetonitrile/water to 100% acetonitrile), fractions analyzed using HPLC (220/254 nm) or
reverse-phase TLC.
Halogenation of racemic alkylcarbastannatranes:
General procedure C:
To an oven-dried screw-top test tube equipped with a stirbar, alkylcarbastannatrane (0.25
mmol) and halogenation reagent (1.5 equiv of Selectfluor I, trichloroisocyanuric acid,
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N-bromosuccinimide, or iodine) were added. The test tube was sealed with a screw-top septum
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3
times using a needle attached to a vacuum manifold. Acetonitrile (1 mL) was added via syringe,
and the reaction mixture was allowed to stir (5 min–1 h) at rt. Once the reaction was complete,
water (0.5 mL) was added to the reaction mixture. For fluorination reactions, the resulting
solution was additionally diluted by ethyl acetate (0.2 mL). Fluorobenzene (0.2 mmol) was
added as an internal 19F NMR standard, and the solution was analyzed by unlocked 19F NMR
spectroscopy and GCMS. For volatile alkyl fluorides, calibrated yields were obtained by 19F
NMR and GC to ensure accuracy of measurement. For other halogenation reactions, the reaction
mixture was diluted with ether and washed with brine. The organic layer was dried over Na2SO4,
filtered, and concentrated to provide the crude product. The crude reaction products were
purified by flash column chromatography (diethyl ether/pentane).
Fluorination of enantioenriched alkylcarbastannatranes:
General procedure D:
To an oven-dried screw-top test tube equipped with a stirbar, the enantioenriched
alkylcarbastannatrane (0.1 mmol) was added. The test tube was sealed with a screw-top septum
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3
times, anhydrous pyridine (0.5 equiv.) was added, and the reaction mixture was then cooled to -5
ºC in a NaCl/ice bath. A solution of Selectfluor I (1.5 equiv) in acetonitrile (1.1 mL) and
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styrene (1 equiv) was added via syringe. After the reaction stirred for 2 h at -5 ºC, water (0.2 mL)
was added. Fluorobenzene (0.05 mmol) was added as an internal standard, and the solution was
analyzed by unlocked 19F NMR spectroscopy. The ee value was determined by HPLC or chiral
GC analysis.
Halogenation (Cl, Br and I) of enantioenriched alkylcarbastannatranes:
General procedure E:
To an oven-dried screw-top test tube equipped with a stirbar, the enantioenriched
alkylcarbastannatrane (0.1 mmol) was added. The test tube was sealed with a screw-top septum
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3
times, then cooled to -5 ºC in a NaCl/ice bath. A solution containing the halogenation reagent
[trichloroisocyanuric acid (0.15 mmol) in CH3CN (1 mL), N-bromosuccinimide (0.15 mmol) in
CH3CN (1 mL), or N-iodosuccinimide (0.15 mmol) in 1 mL THF] was added dropwise via
syringe. After the reaction stirred for 3 h at -5 ºC, water (0.2 mL) was added. The organic layer
was used for GC and HPLC analysis. The GC yield was determined using tetradecane as an
internal calibration standard. The ee value was determined by HPLC or chiral GC analysis.
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5.3. Compound Characterization Data
1-(4-Phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane.[1] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.35 mmol) and
(4-phenylbutan-2-yl)magnesium chloride (4 mmol). A yellow liquid (0.413 g, 78%) was isolated.
1H NMR (500 MHz, CDCl3): δ 7.25-7.28 (m, 2H), 7.16-7.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t,
J = 6.0 Hz, 6H), 1.68-1.81 (m, 2H), 1.65 (quint, J = 6.0 Hz, 6H), 1.13 (d, J = 7.5 Hz, 3H), 0.79
(quart, J = 7.5 Hz, 1H), 0.67 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 143.9,
128.6, 128.3, 125.5, 55.0, 39.0, 36.5, 24.2, 23.6, 18.6, 5.6 ppm.
1-(Dodecan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was employed
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.5 mmol) and dodecan-2-ylmagnesium
chloride (4.4 mmol). A yellow liquid (0.482 g, 75%) was isolated. 1H NMR (500 MHz, CDCl3):
2.34 (t, J = 5.75 Hz, 6H), 1.63 (app. quint, J = 6.6 Hz, 6H), 1.45-1.13 (m, 18H), 1.04 (d, J =
1.51, 3H), 0.88 (t, J = 6.6 Hz, 3H), 0.72 (m, 1H), 0.62 (t, J = 6.7 Hz, 6H) ppm; 13C NMR (125
Sn
N
CH3
Sn
N
CH3H3C 8
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MHz, CDCl3): δ 54.9, 36.6, 32.2, 30.2, 30.1, 29.98, 29.90, 29.6, 24.2, 23.65, 23.55, 22.94, 18.9,
14.4, 5.6 ppm. HRMS (ES+): Calcd (M-Na)+ 444.2341; Found 444.2332.
Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate.[1] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (3 mmol) and
(4-ethoxy-4-oxobutan-2-yl)zinc iodide (6.1 mmol). An yellow oil (509 mg, 45%) was isolated.
1H NMR (500 MHz, CDCl3): δ 4.09 (quart, J = 7.0 Hz, 2H), 2.40 (m, 1H), 2.35 (t, J = 6.0 Hz,
6H), 2.25 (m, 1H), 1.64 (app. quint, J = 6 Hz, 6H), 1.24 (t, J = 7.0 Hz, 3H), 1.02-1.13 (m, 4H),
0.65 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 175.5, 60.0, 54.9, 40.7, 23.5, 19.8,
18.4, 14.6, 5.2 ppm.
The ester derivative could also be prepared using a zincated stannatrane nucleophile via the
following process: Under argon, stannatrane lithium (1 equiv) (prepared via general procedure B)
was added to a 2 M solution of Et2Zn in ether (1 equiv) at 0 ºC. This mixture was allow to stir at
0 ºC for 30 min. It was then added to a solution of ethyl 3-((methylsulfonyl)oxy)butanoate in
hexanes, and allowed to stir overnight at rt. The reaction mixture was washed with water, and
extracted with ether three times. The combined organic layers were dried over Na2SO4, filtered,
concentrated under reduced pressure, and purified by reverse phase flash chromatography
(100% CH3CN). A yellow liquid was isolated (32% yield).
Sn
N
CH3EtO
O
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5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.[1] General procedure A
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.42 mmol) and
(tetrahydro-2H-pyran-4-yl)magnesium chloride (1.26 mmol). A pale yellow solid (121 mg, 84%)
was isolated. 1H NMR (500 MHz, CDCl3): δ 3.87 (m, 2H), 3.33 (dt, J = 11.0, 2.0 Hz, 2H), 2.36
(t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6.0 Hz, 6H), 1.50-1.65 (m, 4H), 0.90 (tt, J = 12.5, 4.0 Hz,
1H), 0.64 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 71.0, 54.8, 31.3, 26.0, 23.4,
4.6 ppm.
5-(1-Phenylethyl)-1-aza-5-stannabicyclo[3.3.3]undecane.[1] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.3 mmol) and
(1-phenylethyl)magnesium chloride (1.5 mmol). A yellow oil (90 mg, 82%) was isolated. 1H
NMR (500 MHz, CDCl3): δ 7.15 (t, J = 7.5 Hz, 2H), 6.90-7.00 (m, 3H), 2.30 (t, J = 6.0 Hz, 6H),
2.21 (quart, J = 7.5 Hz, 1H), 1.61 (app. quint, J = 6.0 Hz, 6H), 1.44 (d, J = 7.5 Hz, 3H), 0.61 (dt,
J = 6.5, 3 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 151.5, 128.0, 124.9, 121.7, 54.7, 32.7,
23.5, 16.7, 5.3 ppm.
SnN O
SnN
CH3
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1-(3-Phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane.[3] General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 mmol) and
(3-phenylpropyl)magnesium chloride (2.5 mmol). A yellow liquid (274 mg, 82%) was isolated.
1H NMR (500 MHz, CDCl3) δ: 7.27-7.14 (m, 5H), 2.53 (t, J = 7.5 Hz, 2H), 2.36 (t, J = 6.2 Hz,
6H), 1.69 (app. quint, J = 6 Hz, 2H), 1.62 (app. quint, J = 6 Hz, 6H), 0.64 (t, J = 6 Hz, 6H), 0.48
(t, J = 6.0 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.6, 128.7, 128.3, 125.5, 54.9, 41.5,
29.9, 23.6, 16.4, 6.8 ppm.
1-Decyl-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was employed using
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2 mmol) decylmagnesium chloride (5 mmol). A
pale yellow solid (538 mg, 67%) was isolated. 1H NMR (500 MHz, CDCl3): δ 2.36 (t, J = 5.5 Hz,
6H), 1.63 (app. quint, J = 6.2 Hz, 6H), 1.26 (m, 16H), 0.88 (t, J = 6.8 Hz, 3H), 0.62 (t, J = 6.6
Hz, 6H); 0.40 (t, J = 8 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3): δ 55.0, 34.9, 32.2, 29.96,
29.95, 29.7, 29.6, 27.4, 23.6, 22.9, 16.4, 14.4, 6.8 ppm. HRMS (ES+): Calcd (M-Na)+ 416.2028;
SnN n-C10H21
Sn
N
H
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Found 416.2021.
1-(4-tert-Butylbenzyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.5 mmol) and
(4-tert-butylbenzyl)magnesium chloride (1.42 mmol). A pale yellow solid (172 mg, 85%) was
isolated. 1H NMR (500 MHz, CDCl3): δ 7.11 (d, J = 8.3 Hz, 2H), 6.81 (d, J = 8.1 Hz, 2H), 2.33
(t, J = 5.7 Hz, 6H), 1.90 (s, 2H), 1.62 (app. quint, J = 6.6 Hz, 6H), 1.27 (s, 9H), 0.64 (t, J = 6.7
Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 144.0, 143.3, 128.2, 126.0, 125.4, 124.9, 54.8,
34.3, 31.8, 26.3, 23.5, 6.7 ppm. HRMS (ES+): Calcd (M-Na)+ 422.1559; Found 422.1557.
5-(Pent-4-en-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure B was employed
using (1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)lithium (9 mmol, 1.5 equiv.) and
pent-4-en-2-yl methanesulfonate (6 mmol, 1 equiv.). The reaction stirred at 25 °C for 3 hours.
The reaction mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL), and
dried over Na2SO4. The reaction solution was filtered and concentrated to provide the crude
SnN
t-Bu
Sn
N
CH2H3C
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product. The crude product was purified by C18 silica (100% acetonitrile). A colorless liquid
(305 mg, 15%) was isolated. 1H NMR (300 MHz, CDCl3): 5.83-5.69 (m, 1H), 4.96-4.86 (m, 2H),
2.35 (t, J = 5.8 Hz, 6H), 2.27-2.05 (m, 2H), 1.68- 1.60 (m, 6H), 1.04 (d, J = 7.5 Hz, 3H),
0.82-0.69 (m, 1H), 0.64 (t, J = 6.5 Hz, 6H) ppm; 13C NMR (75 MHz, CDCl3): 140.8, 113.7,
77.43, 54.9, 40.7, 23.6, 18.3, 5.66 ppm. LCMS Calcd (M-H)+ 330.1240; Found 330.1239.
5-(4,5-bis(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-yl)-1-aza-5-stan-nabicyclo[
3.3.3]undecane. To an oven-dried test tube with screw-top septum,
5-(pent-4-en-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.4 mmol, 1 equiv.), K2CO3 (1.6
mmol, 4 equiv.) and (Bpin)2 (1.2 mmol, 3 equiv.) was added. The reaction tube was evacuated
and backfilled with argon three times. With the tube under a positive pressure of argon, t-BuOH
(anhydrous, 1 mL) and H2O (degassed, 25 μL) were added. The reaction mixture was stirred at
60 oC for 12 h, washed with water and extracted with ether 3 times. The combined organic
layers were dried over Na2SO4, filtered, concentrated under reduced pressure, and purified by
reverse phase flash column chromatography (100% CH3CN). A colorless liquid (165 mg, 71%)
was isolated. The dr for the product is 1:1.2. 1H NMR (300 MHz, CDCl3): 2.33 (t, J = 5.4 Hz, 6
H), 1.66-1.61 (m, 7H), 1.51-1.34 (m, 1H), 1.22 (d, J = 1.3 Hz, 24H), 1.06 -0.98 (m, 3H),
0.83-0.72 (m, 4H), 0.65-0.61 (m, 6H) ppm; 13C NMR (75 MHz, toluene- d8): δ 82.6, 82.5, 54.93
Sn
N
H3C
BPin
BPin
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(minor), 54.92 (major), 40.8, 40.3, 25.13, 25.11, 25.09, 25.05, 25.03, 24.98, 24.96, 24.94, 24.08,
23.94 (minor), 23.92 (major), 23.7, 22.5, 19.0, 18.7, 5.45 (minor), 5.39 (major) ppm. HRMS
(ESI): Calcd (M-Na)+ 606.2932; Found 606.2934.
Sn
N
OHH3C
3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol. To an oven-dried vial with a
stirbar, ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.5 mmol) and LiAlH4 (4
mmol) were added. The vial was sealed with a screw-top septum and electrical tape. The
reaction vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 times. Then, dry ether
(2 mL) was added via syringe. The reaction was stirred overnight at room temperature. The
reaction was quenched with an aqueous solution of NaH2PO4 solution and extracted with hexane
3 times. The combined organic layers were dried over Na2SO4, filtered, concentrated under
reduced pressure. A colorless liquid (141 mg, 85%) was isolated. 1H NMR (500 MHz, CDCl3): δ
3.61 (q, J = 5.6 Hz, 2H), 2.36 (t, J = 5.5 Hz, 6H), 1.75 (m, 1H), 1.65 (quint, J = 5.9 Hz, 6H),
1.16 (m, 1H), 1.07 (d, J = 7.5 Hz, 3H), 0.76 (m, 1H), 0.65 (t, J = 6.6 Hz, 6H) ppm. 13C
NMR(125 MHz, CDCl3): δ 63.3, 54.9, 39.2, 23.6, 19.1, 18.2, 5.4 ppm. HRMS (ES+): Calcd
(M-H)+ 326.1219; Found 326.1219.
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(S)-3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol The preceding procedure was
employed using (S)-3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.15 equiv) and
LiAlH4 (1.2 mmol). A colorless liquid (44 mg, 88%) was isolated.
Preparation of racemic and enantioenriched alkylcarbastannatranes S1, S2, and S3.
OSiMe2t-Bu
OH
H3COH
OH
H3C OSiMe2t-Bu
OMs
H3C
Sn
N
OSiMe2t-BuH3C
Sn
N
OHH3C
Sn
N
OH3C
O
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(S1) (S2) (S3)
OSiMe2t-Bu
OH
H3C
(R)-4-((tert-Butyldimethylsilyl)oxy)butan-2-ol.[4]
To a round bottom flask, 4-(dimethylamino)pyridine (DMAP, 0.5 mmol, 10 mol %),
tert-butyldimethylsilyl chloride (TBDMSCl, 6 mmol, 1.2 equiv), triethylamine (TEA, 10 mmol,
2 equiv), (R)-butane-1,3-diol (5 mmol, or butane-1,3-diol for racemic reaction), and
dichloromethane (DCM, 30 mL) were added. The reaction was stirred overnight at room
temperature. The reaction was quenched by water and extracted with DCM three times. The
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combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure,
and purified by purified by flash column chromatography using ethyl acetate/dichloromethane
(1:9). A colorless liquid (868 mg, 85%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.02 (m,
1H), 3.85 (m, 2H), 3.36 (br s, 1H), 1.65 (m, 2H), 1.19 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.08 (s,
6H) ppm. 13C NMR (75 MHz, CDCl3): δ 68.5, 63.0, 40.2, 26.1, 23.6, 18.3, -5.31, -5.36 ppm.
OSiMe2t-Bu
OMs
H3C
(R)-4-((tert-Butyldimethylsilyl)oxy)butan-2-yl methanesulfonate.[5]
To a round bottom flask, (R)-4-((tert-butyldimethylsilyl)oxy)butan-2-ol (3 mmol,
4-((tert-butyldimethylsilyl)oxy)butan-2-ol for racemic reaction), TEA (6 mmol, 2 equiv), and
anhydrous diethyl ether (20 mL) were added. The reaction flask was cooled to 0 ºC and mesyl
chloride (4.5 mmol, 1.5 equiv) was added. The reaction was allowed to warm to room
temperature and stirred overnight. The reaction was quenched by water and extracted with ether
three times. The combined organic layers were dried over Na2SO4, filtered, concentrated under
reduced pressure, and purified by purified by flash column chromatography (ethyl
acetate/hexane = 1:9). A colorless liquid (771 mg, 91%) was isolated. 1H NMR (300 MHz,
CDCl3): δ 4.95 (m, 1H), 3.71 (m, 2H), 3.0 (s, 3H), 1.84 (m, 2H), 1.47 (d, J = 6.3 Hz, 3H), 0.89
(s, 9H), 0.06 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 77.7, 58.7, 39.7, 38.4, 26.1, 21.9, 18.4,
-5.18, -5.19 ppm.
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Sn
N
OSiMe2t-BuH3C
(S)-5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane
(S1).
General procedure B was followed.[3] The mixture was purified by reverse phase flash column
chromatography (DCM/CH3CN = 1:9). A light yellow oil was isolated (Yield: 40%). The ee
value (97% ee) was determined after deprotection to
3-(5-aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol. 1H NMR (300 MHz, CDCl3): δ 3.56
(m, 2H), 2.35 (t, J = 5.7 Hz, 6H), 1.65 (m, 8H), 1.06 (d, J = 7.2 Hz, 2H), 0.89 (s, 10H), 0.64 (t, J
= 6.7 Hz, 6H), 0.049 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 64.1, 54.9, 39.5, 26.3, 26.3,
26.2, 23.6, 19.6, 18.7, 18.6, 5.4, -4.8, -4.8 ppm. HRMS (ES+): Calcd (M-Na)+ 470.1880; Found
470.1868.
Sn
N
OHH3C
(S)-3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol (S2).
(S)-5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane (0.01
mmol) and THF (0.2 mL) were combined in a 3 mL vial. The vial was cooled to 0 ºC, and TBAF
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(1.2 equiv, 1M in THF) was added dropwise. The reaction was allowed to stir at 0 ºC for 30 min,
and then at room temperature for 3 h. The reaction was quenched with water and extracted with
ether three times. The combined organic layers were dried over Na2SO4, filtered, concentrated
under reduced pressure. The ee value (97% ee) was determined by HPLC analysis. The NMR
spectra of the isolated compound matched that of the racemic sample.
Sn
N
OH3C
O
Ph
(S)-3-(1-Aza-5-stannabicyclo[3.3.3]undecan-5-yl)butyl benzoate (S3).
(S)-5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.2
mmol) (or (5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-
5-stannabicyclo[3.3.3]undecane for the racemic reaction) and THF (0.5 mL) were combined in a
3 mL vial. Tetra-n-butylammonium fluoride (TBAF 0.24 mmol, 1.2 equiv, 1M in THF) was
added dropwise to the vial at rt. The reaction was stirred for 30 min at 0 ºC, and then for 3 h at
room temperature. Triethylamine (0.8 mmol, 4 equiv) and benzoyl chloride (0.8 mmol, 4 equiv)
were then added to the reaction, which was allowed to stir overnight at rt. The reaction was
washed by NaHCO3 (aq.) and extracted with ether three times. The combined organic layers
were dried over Na2SO4, filtered, concentrated under reduced pressure, and purified by purified
by reverse phase flash column chromatography (100% CH3CN). A colorless liquid (77 mg, 88%)
was isolated. The ee value (97% ee) was determined following hydrolysis to
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3-(5-aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol. 1H NMR (300 MHz, CDCl3): δ 8.05
(m, 2H), 7.54 (m, 1H), 7.43 (m, 2H), 4.30 (t, J = 6.7Hz, 2H), 2.36 (t, J = 5.9 Hz, 6H), 2.0-1.81
(m, 2H), 1.65 (m, 6H), 1.13 (d, J = 7.5 Hz, 3H), 0.89-0.80 (m, 1H), 0.68 (t, J = 6.7 Hz, 6H) ppm.
13C NMR (75 MHz, CDCl3): δ 167.0, 132.8, 131.0, 129.8, 128.5, 65.8, 54.9, 35.0, 23.6, 19.8,
18.4, 5.3 ppm. HRMS (ES+): Calcd (M-Na)+ 452.1301; Found 452.1315.
CH3
F
(3-Fluorobutyl)benzene (31) General procedure C was performed using
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I
(0.375 mmol). The fluorinated product was formed in 64% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282
MHz): δ -173.0 (m). 19F NMR spectra are referenced based on the internal standard
fluorobenzene, which is set at –113.6 ppm. The identity of the product was further confirmed by
GCMS analysis. EIMS: m/z (%) = 152.10 (31.02), 132.05 (1.26), 117.05 (13.84), 105.05 (9.18),
91.05 (100). 92.05 (60.77), 77.05 (7.86), 65.05 (13.11), 51.05 (5.37), 39.05 (5.6).
(R)-(3-Fluorobutyl)benzene (73) General procedure D was performed using enantioenriched
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I
(0.15 mmol). Water was added to quench the reaction. The organic layer was run on HPLC to
determine ee value. The fluorinated product was formed in 56% yield as determined by 19F
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NMR spectroscopic analysis of the crude reaction mixture.
F
CH3
(1-Fluoroethyl)benzene (32) General procedure C was performed using
5-(1-Phenylethyl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375
mmol). The fluorinated product was formed in 55% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282
MHz): δ -166.9 (m). 19F NMR spectra are referenced based on the internal standard
fluorobenzene, which is set at –113.6 ppm. The identity of the product was further confirmed by
GCMS analysis. m/z (%) = 124.1 (36.53), 109.05 (100), 103.05 (8.69), 83.5 (8.94), 77.05 (8.44),
63.05 (2.77), 51.05 (9.8), 39.05 (3.55).
CH3
F
H3C
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2-Fluorododecane (34) General procedure C was performed using 1-(dodecan-2-
yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The
fluorinated product was formed in 60% yield as determined by 19F NMR spectroscopic analysis
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -171.6 (m). 19F
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 180.1
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(0.02), 168.15 (2.36), 140.1 (5.13), 125.1 (8.24), 111.1 (20.55), 98.1 (17.43), 97.1 (49.9), 84.1
(38), 83.1 (63.93), 82.1 (18.45) 71.1 (24.14), 70.1 (66.43), 69.1 (79.52), 57.1 (73.51), 56.1
(64.51), 55.1 (88.1), 43.1 (100), 42.1 (24.14), 41.1 (72.35).
CH3
FO
EtO
Ethyl 3-fluorobutanoate (35) General procedure C was performed using ethyl
3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.25 mmol) Selectfluor I (0.375 mmol).
The fluorinated product was formed in 64% yield as determined by 19F NMR spectroscopic
analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -172.0
(m). 19F NMR spectra are referenced based on the internal standard fluorobenzene, which is set
at –113.6 ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) =
134.05 (0.19), 114.05 (5.07), 107.05 (19.46), 99.05 (7.99), 89.05 (100), 87.05 (11.65), 86.05
(9.53), 73.05 (7.52), 69.05 (12.68), 61.05 (42.88), 60 (15.83), 55.1 (5.68), 47.05 (17.48), 45.1
(26.38), 43.5 (20.87), 42.1 (42.33), 41.1 (22.66), 39.05 (6.4), 35.1 (0.01).
(R)-Ethyl-3-fluorobutanoate (75) General procedure D was performed using enantioenriched
ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.1 mmol) and Selectfluor I (0.15
mmol). Water was added to quench the reaction. The organic layer was run on chiral GC to
determine ee value. The fluorinated product was formed in 49% yield as determined by 19F
NMR spectroscopic analysis of the crude reaction mixture.
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3-Fluorobutan-1-ol (37) General procedure C was performed using
3-(5-aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol (0.25 mmol) Selectfluor I (0.375
mmol). After the reaction was complete, triethylamine (2 mmol, 8 equiv) and benzoyl chloride
(1 mmol, 4 equiv) were added to the reaction. The reaction mixture was stirred overnight. The
3-fluorobutyl benzoate was formed in 50% yield as determined by 19F NMR spectroscopic
analysis of the crude reaction mixture. The reaction was washed by water and extracted with
ether 3 times. The combined organic layers were dried over Na2SO4, filtered, concentrated under
reduced pressure, and purified by purified by flash column chromatography. 3-Fluorobutyl
benzoate is isolated as a colorless liquid. See characterization data for # below.
(R)-3-Fluorobutan-1-ol (74) General procedure D was performed using enantioenriched
3-(5-aza-1-stanna-bicyclo[3.3.3]undecan-1-yl) butan-1-ol (0.1 mmol) and Selectfluor I (0.15
mmol). After the reaction was complete, triethylamine (0.8 mmol, 8 equiv) and benzoyl chloride
(0.4 mmol, 4 equiv) were added to the reaction. It was stirred overnight. The reaction was
washed by water and extracted with ether 3 times. The combined organic layers were dried over
Na2SO4, filtered, concentrated under reduced pressure and purified by purified by flash column
chromatography. 3-Fluorobutylbenzoate was isolated as the colorless liquid and run on HPLC to
determine ee value. The fluorinated product was formed in 59% yield as determined by 19F
NMR spectroscopic analysis of the crude reaction mixture.
OH
F
H3C
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2,2'-(4-fluoropentane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (33) General
procedure C was employed using 5-(4,5-
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-2-yl)-1-aza-5-stanna-bicyclo[3.3.3]unde
cane (0.1 mmol) and Selectfluor I (0.15 mmol) in acetonitrile (0.5 mL). The reaction was
washed by water and extracted with ether 3 times. The combined organic layers were dried over
Na2SO4, filtered, concentrated under reduced pressure and purified by purified by flash column
chromatography (ether/hexane = 15:85). A colorless liquid (20 mg, 58%) was isolated. 1H NMR
(300 MHz, CDCl3): δ 4.86-4.75 (m, 0.45H) and 4.69-4.59 (m, 0.55H) indicates a diastereomeric
ratio of 1:1.2, 1.95-1.40 (m, 2H), 1.31 (m, 3H), 1.22 (s, 24H), 1.01-0.75 (m, 3H) ppm; 13C NMR
(75 MHz, CDCl3): δ 91.7 (d, J = 21.4 Hz, major), 89.6 (d, J = 21.8 Hz, minor), 83.2, 77.4, 41.24,
41.13, 40.97, 40.86, 25.11, 25.10, 25.05, 25.03, 25.02, 25, 24.97, 24.93, 21.65 (minor), 21.35
(major) ppm. . 19F NMR (282 MHz, CDCl3): δ -170.63(minor), -172.18 (major) ppm (1F).
HRMS (ESI): Calcd (M-Na)+ 365.2447; Found 365.2449.
(3-Fluoropropyl)benzene (38) General procedure C was performed using 1- (3-
F
H3C
BPin
BPin
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phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375
mmol). The fluorinated product was formed in 52% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282
MHz): δ -219.5 (m). 19F NMR spectra are referenced based on the internal standard
fluorobenzene, which is set at -113.6 ppm. The identity of the product was further confirmed by
GCMS analysis. m/z (%) = 138.1 (31.04), 105.05 (3.52), 92.1 (19.94), 91.05 (100), 77 (4.38), 65
(11.29), 51 (4.79), 39.05 (4.97).
FH3C
7
1-Fluorodecane (40) General procedure C was performed using
1-decyl-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol).
The fluorinated product was formed in 66% yield as determined by 19F NMR spectroscopic
analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -217.8
(m). 19F NMR spectra are referenced based on the internal standard fluorobenzene, which is set
at -113.6 ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) =
160.10 (0.18), 111.10 (10.15), 97.10 (18.91), 85.10 (15.39), 75 (5.51), 69.05 (35.52), 57.10
(68.19), 55.05 (51.08), 61.05 (10.30), 43.1 (100), 41.1 (56.9), 39.05 (9.93).
t-Bu
F
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1-(tert-Butyl)-4-(fluoromethyl)benzene (41) General procedure C was performed using
1-(4-tert-butylbenzyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I
(0.375 mmol). The fluorinated product was formed in 56% yield as determined by 19F NMR
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282
MHz): δ -204.2 (m). 19F NMR spectra are referenced based on the internal standard
fluorobenzene, which is set at -113.6 ppm. The identity of the product was further confirmed by
GCMS analysis. m/z (%) = 166.1 (21.51), 152.1 (11.14), 151.1 (100),
135.05 (4.28), 123.05 (38.56), 116.05 (2.52), 103.05 (4.8), 91.05 (21.99), 77(4.39), 63 (2.19),
57 (2.55), 51.05 (2.90), 41.05 (14.34), 39 (5.66).
4-Fluorotetrahydro-2H-pyran (36) General procedure C was performed using
5-(tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.25 mmol) and
Selectfluor I (0.375 mmol). The fluorinated product was formed in 53% yield as determined by
19F NMR spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/
acetonitrile, 282 MHz): δ -176.5 (m). 19F NMR spectra are referenced based on the internal
standard fluorobenzene, which is set at -113.6 ppm. The identity of the product was further
confirmed by HRMS analysis. HRMS (ES+): Calcd (M)+ 104.0637; Found 104.0640.
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3-Fluorobutyl benzoate[6] (39) General procedure C was performed using
3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butyl benzoate (0.25 mmol) and Selectfluor I
(0.375 mmol). A colorless liquid (34 mg, 70%) was isolated. 1H NMR (500 MHz, CDCl3): δ
8.04 (d, J = 9.5 Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.43 (m, 2H), 4.90 (dm, J = 47.9 Hz, 1H), δ
4.51 – 4.41 (m, 2H), 2.15 – 1.97 (m, 2H), 1.42 (dd, J = 23.9, 6.2 Hz, 3H) ppm. 13C NMR (125
MHz, CDCl3): δ 166.6, 133.2, 130.4, 129.7, 128.6, 88.0 (d, J = 146.9 Hz), 61.2, 36.3 (d, J = 12.3
Hz), 21.3 (d, J = 12.8 Hz) ppm. 19F NMR (282 MHz, CDCl3): δ -175.51 (1F) ppm.
(R)-3-Fluorobutyl benzoate (76) General procedure D was performed using enantioenriched
3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butyl benzoate (0.1 mmol) Selectfluor I (0.15
mmol). After the reaction was done, water was added to quench the reaction. The combined
organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure, and
purified by purified by flash column chromatography. 3-fluorobutyl benzoate is isolated as the
colorless liquid and run on HPLC to determine ee value.
OSiMe2t-Bu
F
H3C
tert-Butyl(3-fluorobutoxy)dimethylsilane (42) General procedure C was performed using
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5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo [3.3.3]undecane (0.25
mmol) and Selectfluor I (0.375 mmol). The fluorinated product was formed in 62% yield as
determined by 19F NMR spectroscopic analysis of the crude reaction mixture. The reaction was
washed by water and extracted with ether 3 times. The combined organic layers were dried over
Na2SO4, filtered, concentrated under reduced pressure, and purified by flash column
chromatography. tert-Butyl(3-fluorobutoxy)dimethylsilane is isolated as the colorless liquid. 1H
NMR (300 MHz, CDCl3): δ 4.97-4.70 (m, 1H), 3.72 (m, 2H), 1.93-1.62 (m, 2H), 1.34 (dd, J =
24.1, 6.2 Hz, 3H), 0.93(s, 9H), 0.059 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 88.2 (d, J =
162.3 Hz) 58.2 (d, J = 5.5 Hz), 40.3 (d, J = 20.4 Hz), 26.1, 21.4 (d, J = 22.3 Hz), 18.5, -5.19,
-5.20 ppm. 19F NMR (282 MHz, CDCl3): δ -175.66 ppm (1F). HRMS (ES+): Calcd (M-Na)+
229.1400; Found 229.1405.
(R)-tert-Butyl(3-fluorobutoxy)dimethylsilane (77) General procedure D was performed using
enantioenriched 5-(4-((tert-butyldimethylsilyl) oxy) butan-2-yl)-1-
aza-5-stannabicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I (0.15 mmol). After the
reaction was done, TBAF (0.12 mmol, 1.2 equiv) was added to the reaction vial at 0 ºC. It was
stirred for 30 min at 0 ºC, then 3h at room temperature. Triethylamine (0.8 mmol, 8 equiv) and
benzoyl chloride (0.4 mmol, 4 equiv) were added to the reaction. It was stirred overnight. The
reaction was washed by water and extracted with ether 3 times. The combined organic layers
were dried over Na2SO4, filtered, concentrated under reduced pressure and purified by purified
by flash column chromatography. 3-fluorobutyl benzoate was isolated as the colorless liquid and
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run on HPLC to determine ee value. The fluorinated product was formed in 59% yield as
determined by 19F NMR spectroscopic analysis of the crude reaction mixture.
1-(3-Chloropropyl)benzene[7] (57) General procedure C was employed using
1-(3-phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and
trichloroisocyanuric acid (0.375 mmol). A colorless liquid (25 mg, 65%) was isolated. 1H NMR
(500 MHz, CDCl3): δ 7.31-7.28 (m, 2H), 7.22-7.19 (m, 3H), 3.54-3.52 (t, J = 6.5 Hz, 2H),
2.80-2.77 (t, J = 7.4 Hz, 2H), 2.11-2.07 (quint, J = 7.4, 6.7 Hz, 2H) ppm. 13C NMR (125 MHz,
CDCl3): δ 140.9, 128.7, 128.6, 126.3, 44.5, 34.2, 33.0 ppm.
1-(3-bromopropyl)benzene[7] (58) General procedure C was employed using
1-(3-phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and
N-bromosuccinimide (0.375mmol). A colorless liquid (41 mg, 82%) was isolated. 1H NMR (500
MHz, CDCl3): δ 7.31-7.28 (m, 2H), 7.22- 7.19 (m, 3H), 3.38 (t, J = 6.6 Hz, 2H), 2.78 (t, J = 7.3
Hz, 2H), 2.20- 2.15 (m, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 140.7, 128.75, 128.7, 126.4,
34.4, 34.2, 33.3 ppm.
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1-(3-iodopropyl)benzene[7] (59) General procedure C was employed using
1-(3-phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and iodine (0.375
mmol). A colorless liquid (42 mg, 68%) was isolated. 1H NMR (500 MHz, CDCl3): δ 7.31- 7.28
(m, 2H), 7.22- 7.19(m, 3H), 3.17 (t, J = 6.8 Hz, 2H), 2.73 (t, J = 7.2 Hz, 2H), 2.16- 2.22 (m, 2H)
ppm. 13C NMR (125 MHz, CDCl3): δ 140.6, 128.77, 128.71, 126.4, 36.4, 35.1, 6.5 ppm.
1-(3-Chlorobutyl)benzene (54)[8] General procedure C was employed using compound
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.25 mmol) and
trichloroisocyanuric acid (0.375 mmol). A colorless liquid (26 mg, 62%) was isolated. 1H NMR
(500 MHz, CDCl3): δ 7.31-7.28 (m, 2H), 7.21-7.20 (m, 3H), 4.03-3.96 (m, 1H), 2.88-2.83 (m,
1H), 2.77-2.71 (m, 1H), 2.06-1.95 (m, 2H), 1.54(d, J = 6.6 Hz, 3H) ppm. 13C NMR(125 MHz,
CDCl3): δ 141.3, 128.7, 128.6, 126.2, 58.1, 42.1, 33.0, 25.6 ppm.
(R)-(3-Chlorobutyl)benzene (78) General procedure E was performed using enantioenriched
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.1 mmol) and
Cl
CH3
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trichloroisocyanuric acid (0.15 mmol). After the reaction was done, water was added to quench
the reaction. The ee value (93% ee) was determined by HPLC analysis of the organic layer. The
yield (81%) was determined by calibrated gas chromatography.
1-(3-Bromobutyl)benzene (55)[9] General procedure C was employed using compound
enantioenriched 1-(4-phenylbutan-2-yl) -5-aza-1-stanna-bicyclo[3.3.3] undecane (0.25 mmol)
and N-bromosuccinimide (0.375 mmol). A colorless liquid (32 mg, 60%) was isolated. 1H NMR
(500 MHz, CDCl3): δ 7.32-7.28 (m, 2 H), 7.22-7.18 (m, 3 H), 4.11-4.05 (dqd, J = 9.0, 6.5, 4.5
Hz, 1 H), 2.87 (ddd, J = 14.0, 9.0, 5.5 Hz, 1 H), 2.74 (ddd, J = 14.0, 9.0, 7.0 Hz), 2.17-2.02 (m,
2 H), 1.73 (d, J = 6.7 Hz, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ 141.1, 128.7, 128.6, 126.2,
51.0, 42.9, 34.2, 26.7 ppm.
(R)-(3-Bromobutyl)benzene (79) General procedure E was performed using enantioenriched
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.1 mmol) and
N-bromosuccinimide (0.15 mmol). After the reaction was done, water was added to quench the
reaction. The ee value (97% ee) was determined by HPLC analysis of the organic layer. The
yield (71%) was determined by calibrated gas chromatography.
I
CH3
Br
CH3
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1-(3-Iodobutyl)benzene (56)[9] General procedure C was employed using compound
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and iodine (0.375
mmol). A colorless liquid (41 mg, 63%) was isolated. 1H NMR (500 MHz, CDCl3): δ 7.31-7.28
(m, 2 H), 7.22-7.21 (m, 3 H), 4.15-4.08 (dqd, J = 9.0, 7.0, 4.5 Hz, 1 H), 2.88-2.82 (ddd, J = 14.0,
9.0, 5.0 Hz, 1 H), 2.73-2.67 (ddd, J = 14.0, 9.0, 7.0 Hz, 1 H), 2.18-2.12 (dtd, J = 14.5, 9.0, 5.0
Hz, 1 H), 1.95 (d, J = 6.9 Hz, 3 H), 1.92-1.85 (dddd, J = 14.5, 9.0, 7.0, 5.0 Hz, 1 H) ppm. 13C
NMR (125 MHz, CDCl3): δ 140.7, 128.7, 128.6, 126.2, 44.6, 36.0, 29.8, 29.2 ppm.
(R)-(3-Iodobutyl)benzene (80) General procedure E was performed using enantioenriched
1-(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and
N-iodosuccinimide (0.15 mmol). After the reaction was done, water was added to quench the
reaction. The ee value (92% ee) was determined by HPLC analysis of the organic layer. The
yield (52%) was determined by calibrated gas chromatography.
Use of enantioenriched benzylcarbastannatrane in fluorination reaction:
Sn
N
CH3
Ph
N
N
Cl
F
2BF4 CH3CN, -5 ºC, 5 min
1
styrene (1 equiv)
pyridine (1 equiv)
F
CH3
Ph
99% ee
50% yield
53% ee
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5.4. Investigation of the Stereochemical Course of the Fluorination Reaction.
OH
CH3
F
CH3
(S4)
DAST
(S)-1-(3-Fluorobutyl)benzene (S4)[10] At -78 ºC, to the vial with (R)-4-phenylbutan-2-ol (1
mmol) in DCM (5 mL) was added diethylaminosulfur trifluoride (DAST, 1.2 mmol, 1.2 equiv.)
under Ar. The reaction was warmed to room temperature slowly and stirred overnight. The
reaction was quenched by water and extracted with ether 3 times. The combined organic layers
were dried over Na2SO4, filtered, concentrated under reduced pressure and purified by purified
by flash column chromatography. A colorless liquid (80.6 mg, 53%) was isolated. 1H NMR (300
MHz, CDCl3): 7.33-7.26 (m, 2H), 7.23-7.17 (m, 3H), 4.66 (dm, J = 49.1Hz, 1H), 2.86-2.64 (m,
2H), 2.08-1.71 (m, 2H), 1.35 (dd, J = 24.0 Hz, 6.18 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ
141.7, 128.6, 126.1, 90.3 (d, J = 162.8 Hz), 38.9 (d, J = 22.5 Hz), 31.6 (d, J = 4.8 Hz), 21.2 (d, J
= 22.5 Hz) ppm; 19F NMR (282 MHz, CDCl3) δ -174.2 (1F).
(R)-(3-Fluorobutyl)benzene (S5). General procedure D was employed using
(S)-5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane (0.025 mmol, prepared from
Sn
N
CH3
Selectfluor I
F
CH3
(S5)
81
(R)-4-phenylbutan-2-yl methanesulfonate[3]). After the reaction was complete, water was added
to quench the reaction. The ee value (84% ee) was determined by HPLC analysis of the organic
layer. The yield (54%) was determined by calibrated gas chromatography.
F
CH3
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Conditions:
Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile]:H2O = 61%: 39%
Flow rate 0.8 mL/min
Detector 254 nm
Temperature 25 ºC
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5.6. GC Data Supporting Absence of Protodestannylation
Sn
N
CH3
and GC decomposition products
CH3CN, rt, 5 min
Sn
N
CH3
1 (1.5 equiv)
CH3
F
5
CH3
F
from crude reaction
1.972 min
tetradecane internal standard
CH31.813 min
Sigma-Aldrich
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5.7. Chiral HPLC and GC Data
Conditions and results:
Column IA-3 m 150x4.6
Mobile Phase Hexane : IPA = 100 : 0.1
Flow 0.6 mL/min
Detector 220 nm
Temp 25°C
Result >99% ee
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Conditions and results:
Column Chiralcel OJ-H 250x4.6
Mobile Phase Methanol : Water = 95% : 5%
Flow 1.0 mL/min
Detector 215 nm
Temp 25°C
Result 99% ee
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Compound S2
Conditions and results
Column IA 250x4.6
Mobile phase Hexane : IPA = 90% : 10%
Flow rate 0.3 mL/min
Detector 210 nm
Temperature 25 ºC
Result 97% ee
Sn
N
OHH3C
Sn
N
OHH3C
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Conditions and results:
Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile] : H2O = 61% : 39%
Flow rate 0.8 mL/min
Detector 254 nm
Temperature 25 ºC
Result 82 % ee, 85% es
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89
Conditions and results:
Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer
(25mM, pH 7.8) = 60%: 40%
Flow rate 0.8 mL/min
Detector 254 nm
Temperature 25 ºC
Result 89% ee, 90% es
89% ee, 90% es
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Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer
(25mM, pH 7.8) = 60% : 40%
Flow rate 0.8 mL/min
Detector 254 nm
Temperature 25 ºC
Result 86% ee, 89% es
Conditions and results:
Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer
(25mM, pH 7.8) = 60% : 40%
Flow rate 0.8 mL/min
Detector 254 nm
Temperature 25 ºC
Result 80% ee, 83% es
86% ee, 89% es
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77
91
75
87% ee (88% es)
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Conditions and results:
Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile]:H2O = 60% : 40%
Flow rate 0.9 mL/min
Detector 210 nm
Temperature 25 ºC
Result 93% ee (95% es)
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93
79
97% ee (98% es)
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Conditions and results:
Column IA 250x4.6
Mobile phase [19:1 v/v Methanol/Acetonitrile]:H2O = 70% : 30%
Flow rate 0.8 mL/min
Detector 254 nm
Temperature 25 ºC
Result 92% ee, 94% es
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5.8. 1H and 13C NMR spectra
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